Antonello Pietrangelo
#134,440
Most Influential Person Now
Researcher
Antonello Pietrangelo's AcademicInfluence.com Rankings
Download Badge
Physics
Antonello Pietrangelo's Degrees
- PhD Physics University of Milan
- Masters Physics University of Milan
- Bachelors Physics University of Milan
Why Is Antonello Pietrangelo Influential?
(Suggest an Edit or Addition)Antonello Pietrangelo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hereditary hemochromatosis--a new look at an old disease. (2004) (937)
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study (2020) (758)
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism (2009) (722)
- Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. (2001) (565)
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia (2020) (564)
- Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. (2010) (516)
- Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing (2016) (334)
- STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. (2007) (303)
- Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. (2001) (301)
- ER Stress Controls Iron Metabolism Through Induction of Hepcidin (2009) (291)
- Iron regulatory proteins in pathobiology. (2000) (285)
- Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. (1999) (255)
- Heterogeneity of hemochromatosis in Italy. (1998) (241)
- The ferroportin disease (2014) (229)
- Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells (1992) (213)
- EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). (2003) (204)
- Hemochromatosis: An endocrine liver disease (2007) (200)
- Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. (2003) (190)
- The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. (2002) (179)
- Antioxidant activity of silybin in vivo during long-term iron overload in rats. (1995) (168)
- Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis (1999) (168)
- Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)‐SMAD signaling pathway in mice (2011) (165)
- The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. (2003) (163)
- Metals, oxidative stress, and hepatic fibrogenesis. (1996) (163)
- Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. (2008) (160)
- Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. (1992) (155)
- Haemochromatosis (2003) (151)
- Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. (2009) (149)
- Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. (2000) (145)
- Iron, oxidative stress and liver fibrogenesis. (1998) (143)
- Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. (2005) (139)
- Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. (1995) (137)
- Physiology of iron transport and the hemochromatosis gene. (2002) (136)
- Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. (2010) (130)
- Ferroportin disease: A systematic meta-analysis of clinical and molecular findings☆ (2010) (126)
- Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB (2014) (121)
- Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. (2002) (118)
- Hepcidin in human iron disorders: therapeutic implications. (2011) (118)
- The ferroportin disease. (2014) (112)
- Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. (2015) (111)
- Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice (2014) (106)
- BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. (2010) (104)
- A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis (2010) (103)
- Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. (2010) (101)
- Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. (2016) (99)
- Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. (1997) (95)
- Duodenal ferritin synthesis in genetic hemochromatosis. (1995) (94)
- Enhanced hepatic collagen type I mRNA expression into fat‐storing cells in a rodent model of hemochromatosis (1994) (93)
- Non-HFE hepatic iron overload. (2011) (92)
- Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia. (2019) (89)
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (2020) (87)
- Ferroportin disease: pathogenesis, diagnosis and treatment (2017) (87)
- Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. (1992) (84)
- Iron and the liver (2016) (83)
- EASL International Consensus Conference on Haemochromatosis (2000) (81)
- POPDC1(S201F) causes muscular dystrophy and arrhythmia by affecting protein trafficking. (2016) (80)
- BMP-6 is a key endogenous regulator of hepcidin expression and iron metabolism (2010) (75)
- Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study (2017) (73)
- Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. (2001) (72)
- Hemochromatosis gene modifies course of hepatitis C viral infection. (2003) (72)
- Liver gene expression during chronic dietary iron overload in rats (1990) (70)
- Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload (2005) (70)
- Transferrin receptor gene expression during rat liver regeneration. Evidence for post-transcriptional regulation by iron regulatory factorB, a second iron-responsive element-binding protein. (1994) (70)
- Iron-induced oxidant stress in alcoholic liver fibrogenesis. (2003) (69)
- C/EBP-β/LAP Controls Down-regulation of Albumin Gene Transcription during Liver Regeneration* (1996) (68)
- Non‐HFE hemochromatosis (2004) (67)
- Iron in NASH, chronic liver diseases and HCC: how much iron is too much? (2009) (67)
- Non-HFE hemochromatosis. (2005) (67)
- Mechanisms of Disease: the role of hepcidin in iron homeostasis—implications for hemochromatosis and other disorders (2004) (67)
- Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. (1994) (63)
- HJV gene mutations in European patients with juvenile hemochromatosis (2005) (61)
- Mechanism of iron toxicity. (2002) (60)
- Iron and steatohepatitis (2012) (56)
- Huh‐7: A human “hemochromatotic” cell line (2010) (55)
- Molecular insights into the pathogenesis of hereditary haemochromatosis (2006) (54)
- Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. (1986) (53)
- Iron-Induced Oxidant Stress Leads to Irreversible Mitochondrial Dysfunctions and Fibrosis in the Liver of Chronic Iron-Dosed Gerbils. The Effect of Silybin (2000) (52)
- Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion (1986) (52)
- Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation. (1995) (52)
- Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. (2006) (50)
- Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. (2002) (50)
- Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity (2009) (49)
- Molecular and clinical correlates in iron overload associated with mutations in ferroportin. (2006) (49)
- Hereditary hemochromatosis. (2006) (46)
- Iron-Induced Oxidant Stress in Nonparenchymal Liver Cells: Mitochondrial Derangement and Fibrosis in Acutely Iron-Dosed Gerbils and Its Prevention by Silybin (2002) (45)
- Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis (2019) (45)
- Hepatitis B virus infection in porphyria cutanea tarda. (2008) (41)
- Impaired Iron Transport Activity of Ferroportin 1 in Hereditary Iron Overload (2005) (41)
- Molecular genetics and control of iron metabolism in hemochromatosis. (1998) (41)
- Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C (2009) (40)
- Altered hepatic BMP signaling pathway in human HFE hemochromatosis. (2010) (40)
- Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis (1991) (40)
- Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol (2020) (39)
- Haptoglobin modifies the hemochromatosis phenotype in mice. (2005) (38)
- Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease (2019) (38)
- Lipid composition and fluidity of liver mitochondria, microsomes and plasma membrane of rats with chronic dietary iron overload. (1990) (36)
- Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types. (1989) (36)
- Iron chelation beyond transfusion iron overload (2007) (36)
- Human macrophage ferroportin biology and the basis for the ferroportin disease (2017) (36)
- Hepatic stellate cells are not subjected to oxidant stress during iron‐induced fibrogenesis in rodents (1998) (34)
- The role of Ito cells in the biosynthesis of HGF-SF in the liver. (1993) (34)
- Inherited metabolic disease of the liver (2009) (30)
- Lack of enterocyte iron accumulation in the ferroportin disease. (2005) (30)
- Lack of coordinate control of ferritin and transferrin receptor expression during rat liver regeneration (1998) (30)
- Hepatic stellate cell nomenclature. (1996) (30)
- 3-Hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo. (2001) (30)
- Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) (2021) (29)
- Mechanisms of iron hepatotoxicity. (2016) (29)
- Hemochromatosis 1998: is one gene enough? (1998) (29)
- Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. (2013) (29)
- Ferroportin is a monomer in vivo in mice. (2006) (28)
- Expression of messenger RNA for liver functions following 70% and 90% hepatectomy. (1996) (27)
- Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients h (2018) (26)
- Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis. (1998) (25)
- Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. (2010) (25)
- Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. (2021) (24)
- Current challenges in the management of patients with sickle cell disease – A report of the Italian experience (2019) (24)
- Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study (2021) (24)
- The SMAD Pathway Is Required for Hepcidin Response During Endoplasmic Reticulum Stress. (2016) (23)
- Disease progression and liver cancer in the ferroportin disease (2007) (23)
- Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients (2019) (23)
- Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis. (2016) (22)
- Translational regulation of ferritin synthesis in rat liver. Effects of chronic dietary iron overload. (1989) (21)
- Homeostatic regulation of hepatocyte nuclear transcription factor 1 expression in cultured hepatoma cells. (1994) (19)
- Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? (2020) (19)
- Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor. (2014) (19)
- Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? (1985) (19)
- Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia (2018) (18)
- Genetic iron overload disorders. (2020) (18)
- Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. (1995) (17)
- Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study (2019) (17)
- Non-invasive assessment of hepatic iron overload: are we finally there? (2005) (16)
- Coproporphyrin excretion in healthy newborn babies. (1984) (16)
- Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator (2020) (16)
- Pain and Frailty in Hospitalized Older Adults (2020) (15)
- Iron, friend or foe? "Freedom" makes the difference. (2000) (15)
- Comorbidity does not mean clinical complexity: evidence from the RePoSI register (2019) (15)
- Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia (2016) (15)
- Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 (2021) (14)
- Pathogens, Metabolic Adaptation, and Human Diseases--An Iron-Thrifty Genetic Model. (2015) (14)
- Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
- DNA repair in lymphocytes from humans and rats with chronic iron overload. (1988) (12)
- Design, synthesis, and physicochemical and biological characterization of a new iron chelator of the family of hydroxychromenes. (2002) (12)
- Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion. (2008) (11)
- Luspatercept (ACE-536) Reduces Disease Burden, Including Anemia, Iron Overload, and Leg Ulcers, in Adults with Beta-Thalassemia: Results from a Phase 2 Study (2015) (11)
- First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy (2022) (11)
- British Association for the Study of the Liver (1991) (11)
- Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation. (2021) (11)
- G80S-linked ferroportin disease: the first clinical description in a Greek family. (2008) (10)
- Genetics in liver diseases. (2007) (10)
- LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH BETA-THALASSEMIA (2016) (9)
- Multicenter observational study on the reliability of the HEART score (2019) (9)
- The penetrance of hemochromatosis: mice to the rescue. (2007) (8)
- Hereditary hemochromatosis masquerading as rheumatoid arthritis. (2001) (8)
- 187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS (2009) (8)
- A Phase I/II, Open-Label, Dose-Escalation Trial of Once-Daily Oral Chelator Deferasirox to Treat Iron Overload in HFE-Related Hereditary Hemochromatosis: Final Results of the Core Study. (2009) (7)
- Juvenile Hemochromatosis, Genetic Study and Long-term Follow up after Therapy (2014) (7)
- RETRACTED ARTICLE: The porphyrias: pathophysiology (2010) (7)
- Association between celiac disease and idiopathic dilated cardiomyopathy: a case report (2011) (7)
- Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy (2020) (7)
- Hemochromatosis and Hemojuvelin G320V Homozygosity in a Hungarian Woman (2010) (6)
- Porphyria cutanea tarda in beta-thalassemia trait carriers. (1984) (6)
- 5 – Disorders of iron overload (2012) (6)
- Hepcidin and iron (2015) (6)
- Hepcidin Activation During Inflammation: Make It STAT (2007) (6)
- Diacerhein blocks iron regulatory protein activation in inflamed human monocytes. (1998) (6)
- An unfortunate case of post-ERCP complications (2017) (6)
- Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection (2021) (6)
- Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene (2014) (5)
- Hyperferritinemia and diagnosis of type 1 Gaucher disease (2020) (5)
- Strategies for liver support: from stem cells to xenotransplantation. (2004) (5)
- Design of an Ongoing Phase I/II Open-Label, Dose-Escalation Trial Using the Oral Chelator Deferasirox To Treat Iron Overload in HFE-Related Hereditary Hemochromatosis (HH). (2007) (5)
- The impact of inherited thrombophilia on liver transplantation. (2009) (5)
- Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload (1989) (5)
- Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study. (2021) (5)
- ZAP-70 expression in chronic lymphocytic leukemia: a new parameter for an old disease (2003) (4)
- Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis (2020) (4)
- Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005. (2006) (4)
- Impact of natural neuromedin‐B receptor variants on iron metabolism (2019) (4)
- Ursodeoxycholic Acid Complexation with 2-Hydroxypropyl-β-Cyclodextrin Increases Ursodeoxycholic Acid Biliary Excretion after Single Oral Administration in Rats (2001) (4)
- Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry (2022) (4)
- Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
- Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
- Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives (2022) (4)
- Metal storage disorders. Forward. (2011) (4)
- Modulation of the synthesis of apolipoproteins in rat hepatoma cells. (1988) (3)
- Juvenile hemochromatosis. (2006) (3)
- Enhanced hepatic collagen gene expression in a rodent model of haemochromatosis (1992) (3)
- Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
- Post COVID-19 irritable bowel syndrome (2022) (3)
- C/EBP- (cid:98) /LAP Controls Down-regulation of Albumin Gene Transcription during Liver Regeneration* (1996) (3)
- Endothelial Dysfunction in Acute Hepatic Porphyrias (2022) (3)
- Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) (2004) (3)
- The SLC11A3 gene, encoding for a main iron export protein, is controlled posttranscriptionally by iron (2002) (3)
- Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications (2022) (3)
- Impact of COVID-19 pandemic on medication use in the older Italian population (2022) (3)
- In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia. (2019) (3)
- A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages (2022) (3)
- Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia (2022) (2)
- Proteins of iron metabolism: by Ugo Testa. 608 pp. $209.95. CRC press, LLC, Atlanta, Georgia, 2001. ISBN 0849386764. Web address for ordering: www.crcpress.com (2003) (2)
- Iron and the liver. (2004) (2)
- Short-Term Branched Chain Amino Acid Parenteral Nutrition in Liver Cirrhosis: A Dose-Related Effect on Plasma Amino Acids and Nitrogen Balance (1984) (2)
- What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group. (2017) (2)
- Missed treatment in an Italian HBV infected patients cohort: HBV RER. (2016) (2)
- VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS (1993) (2)
- MOLECULAR AND CELLULAR ASPECTS OF LIVER-DISEASE IN GENETIC HEMOCHROMATOSIS (1995) (2)
- Is poor vitamin status a reliable target for treatment of symptomatic patients with hepatic acute porphyrias? (2019) (2)
- Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
- Rare ceruloplasmin variants are associated with hyperferritinemia and increased hepatic iron in NAFLD patients: results from a NGS study (2018) (2)
- No HFE, no HLA, no 6p-linked adult hemochromatosis: A new genetic iron overload condition (1998) (2)
- Reducing the risk of hospital admission: a call to action from the Italian Society of Internal Medicine. (2015) (2)
- Impact of implementing a Choosing Wisely educational intervention into clinical practice: The CW-SIMI study (a multicenter-controlled study). (2021) (2)
- Studies on the regulation of liver gene expression in experimental and human siderosis (1991) (2)
- Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis (2017) (2)
- Internists or specialists-that is the question! (2022) (2)
- 215 IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? (2013) (2)
- Idiopathic brain calcification in a patient with hereditary hemochromatosis (2020) (2)
- LUSPATERCEPT INCREASES HEMOGLOBIN, REDUCES LIVER IRON CONCENTRATION, AND IMPROVES QUALITY OF LIFE IN NON-TRANSFUSION DEPENDENT ADULTS WITH BETA-THALASSEMIA (2016) (1)
- Clinical outcomes and survival in patients with hepatocellular carcinoma and HIV infection. (2010) (1)
- Correction to: Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (1)
- Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major (2008) (1)
- Ataxia-Myoclonus Syndrome in Patients with SARS-CoV-2 Infection (2021) (1)
- Regulation of ferroportin (SLC11A3) gene by iron (2002) (1)
- Randomized, Open Label, Phase IIa Controlled Trials Evaluating the Safety of the Association of Deferasirox with Standard Antiviral Therapy (Peg-interferon and Ribavirin) in Patients with Chronic Hepatitis C (2014) (1)
- Iron overload in rodents leads to hepatic cirrhosis through enhancement of collagen gene expression into non-parenchymal cells. (1994) (1)
- [587] ANTIVIRAL TREATMENT PROFOUNDLY AFFECTS IRON STATUS IN HCV PATIENTS: IMPLICATIONS FOR MANAGEMENT AND TREATMENT OUTCOME (2007) (1)
- 4 – Disorders of Iron Overload (2018) (1)
- Hereditary hemochromatosis. (2006) (1)
- [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis]. (1984) (1)
- Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study. (2021) (1)
- The impact of COVID-19 pandemic on well-being of Italian physicians: a report from the Italian Society of Internal Medicine (SIMI) national survey (2022) (1)
- [Hereditary coproporphyria. A familial study]. (1984) (1)
- [Diagnosis of digestive diseases]. (1990) (1)
- Corrigendum to “Ferroportin disease: A systematic meta-analysis of clinical and molecular findings” J. Hepatol. 2010 Nov;53(5):941–949 (2011) (1)
- Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? (2022) (1)
- Cross-talk between regulation of iron homeostasis and gluconeogenesis in a murine model of hereditary hemochromatosis (2020) (0)
- 92 THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS (2011) (0)
- Dynamics and correlates of iron biomarkers in chronic hepatitis C patients undergoing antiviral treatment: an interim report (2006) (0)
- Defective control or iron metabolism in pre-neoplastic liver nodules during experimental carcinogenesis (1996) (0)
- Hereditary haemochromatosis: the genes and the disease (2006) (0)
- Hepatitis C virus-induced reactive oxygen species cause iron accumulation in mice by reducing hepcidin transcription (2007) (0)
- Primary hypoparathyroidism is common in adult patients with [beta]-thalassemia and protect patients from osteoporosis (2015) (0)
- Effect of anti-osteoarthritic drugs on interleukin 1-dependent activation of NF-kappa B in human chondrocytes (2007) (0)
- Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register. (2023) (0)
- SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. (2013) (0)
- Fortune favours the bold: finding the right route in the anemia's sea (2016) (0)
- Solving hemochromatosis with knock-out mice. (2003) (0)
- Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization (2015) (0)
- An update of the genetic status of the 55 Italian hemochromatosis patients with incomplete or negative HFE genotypes (2002) (0)
- Intravenous fat and glucose in liver cirrhosis (1987) (0)
- Epidemiology of porphyrias in Italy: rare complex diseases with liver involvement- data from the registry of Gruppo Italiano Porfiria (GrIP) (2019) (0)
- Late breaking abstracts (2005) (0)
- F-28 Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis (2013) (0)
- Book Review Hemochromatosis: Genetics, pathophysiology, diagnosis and treatment Edited by James C. Barton and Corwin Q. Edwards. 616 pp., illustrated. New York, Cambridge University Press, 2000. $215. 0-521-593808 (2000) (0)
- Studies in Hemochromatosis Type 3: How Does TfR2 Control Hepatic Hepcidin Expression? (2012) (0)
- SALIVARY TYPE HYPERAMYLASEMIA IN CHRONIC LIVER-DISEASE (1985) (0)
- Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension (2015) (0)
- 203 ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? (2010) (0)
- Esters of hyaluronic acid with the Rhine, the manufacturing processes for it and thus compositions (2005) (0)
- Homeostatic control of hepatocyte nuclear transcription factor-1 activity and albumin gene expression in cultured hepatoma cells (1993) (0)
- Introduction (2007) (0)
- OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME (2023) (0)
- Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
- W1848 Keratin Variants Associate with Primary Biliary Cirrhosis (2008) (0)
- IRON IS A MITOGENIC AND PROFIBROGENIC FACTOR IN EXPERIMENTAL LIVER FIBROSIS DUE TO IRON OVERLOAD (1994) (0)
- A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX (2016) (0)
- Consensus Statement on the definition and classification of metabolic hyperferritinaemia (2023) (0)
- Molecular and Cellular Aspects of Iron-Mediated Liver Toxicity (1996) (0)
- Sex hormones differently regulate hepatic hepcidin expression and systemic iron homeostasis in vivo (2014) (0)
- Myocardial fibrosis by delayed enhancement cardiovascular magnetic resonance and HCV infection in thalassemia major patients (2010) (0)
- THE BMP'S PATHWAY IN HEPCIDIN REGULATION DURING ENDOPLASMIC RETICULUM STRESS RESPONSE. (2013) (0)
- Thyroid volume in adult beta-thalassemic patients is smaller than in controls (2014) (0)
- AJG-21-1347 147..157 (0)
- P281 GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN (2014) (0)
- Authors' response to "Measuring serum hepcidin concentrations" (2005) (0)
- A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox (2017) (0)
- The Natural History of Ferroportin Disease – First Results of the International, Multicenter non-HFE Registry (2019) (0)
- 1025 MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS (2013) (0)
- Erratum to: The porphyrias: pathophysiology (2011) (0)
- Clinical Questions in Iron Overload (2009) (0)
- 742 EFFICACY AND SAFETY OF ENTECAVIR (ETV) PROPHYLAXIS IN INACTIVE HBV CARRIERS WHO UNDERWENT CHEMOTHERAPY FOR SOLID OR HAEMATOLOGICAL CANCER: INTERIM ANALYSIS OF A COHORT STUDY (2013) (0)
- The S65C mutation of HFE may contribute to iron overload in C282Y heterozygotes. (2000) (0)
- HLA-H mutations in Italian patients with genetic hemochromatosis: Evidence of genetic heterogeneity (1997) (0)
- Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin (2023) (0)
- F-13 Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C (2012) (0)
- A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review (2023) (0)
- THE IMPACT OF DISEASE CAUSING MUTATIONS AND BENIGN SEQUENCE VARIANTS OF FERROPORTIN ON IRON EXPORT AND HEPCIDIN RESPONSE. (2011) (0)
- Relationship between Pattern of Hepatic Iron Deposition, Disease Severity and Clinical Outcomes in Non-Alcoholic Fatty Liver Disease (2016) (0)
- A pediatric case report of acute intermittent porphyria: Learning the lesson (2014) (0)
- Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study (2023) (0)
- 5 BETTER SUSTAINED CONTROL OF CHRONIC GENOTYPE 1 HCV INFECTIONS WITH PEG-IFN ALFA-2A THAN WITH PEG-IFN ALFA-2B TREATMENT: RESULTS OF DAILY CLINICAL PRACTICE (2010) (0)
- Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. (1998) (0)
- T-29 Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis (2013) (0)
- Labile plasma iron and echocardiographic parameters are associated with cardiac events in β‐thalassemic patients (2023) (0)
- Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients (2022) (0)
- Transcription of the albumin gene is down regulated by albumin or macromolecule infusion in the rat (1991) (0)
- T-13 Entecavir (ETV) prophylaxis in inactive HBV carriers who underwent chemotherapy for solid or haematological cancer: interim analysis of a cohort study (2013) (0)
- P1070 FIRST LINE TREATMENT FOR CHRONIC HEPATITIS B (CH-B) IN REAL LIFE. AN ITALIAN MULTICENTER OBSERVATIONAL COHORT (HBV-RER) (2014) (0)
- Oxidant stress: cell signalling and gene response in the liver: the iron-oxygen connection. (1998) (0)
- F-11 Combination of radiofrequency ablation and transcatheter arterial chemoembolization improves survival in advanced hepatocellular carcinoma complicating liver cirrhosis (2012) (0)
- 30 HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCC AND LIVER CIRRHOSIS (2010) (0)
- Clinical and genetic characterization of autosomal dominant hereditary iron overload (2002) (0)
- Treatment of chronic hepatitis C by pegylated interferon plus ribavirin combination therapy in aged patients : why not ? (2011) (0)
- Mixed hepatic iron deposition but not serum ferritin is associated with the presence of nonalcoholic steatohepatitis (NASH) (2018) (0)
- LBP-32-The Natural History of Ferroportin Disease-First Results of the International, Multicenter EASL non-HFE Registry (2019) (0)
- Iron transporter ferroportin FPN1 (2003) (0)
- British Association for the Study of the Liver Meeting (2000) (0)
- An unusual dyspnea in an 87-year old woman affected by Sjögren’s syndrome (2021) (0)
- Sudden Onset of Lower Abdominal Pain Without Peritonitis or Ileus (2016) (0)
- MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma (2009) (0)
- O.65 Nutritional effects of branched chain amino acid alone and enriched parenteral solutions in liver cirrhosis (1983) (0)
- PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
- State-of-the-Art Lecture II: Hereditary haemochromatosis: the genes and the disease (2007) (0)
- Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis (2014) (0)
- [Internal medicine evaluation of the surgical risk in cirrhosis patients]. (1987) (0)
- P1270 SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO (2014) (0)
- foe? "Freedom" makes (2000) (0)
- Serum HBsAg and ddPCR HBV-DNA as predictive parameters of HBsAg loss after nucleo(s)tide analogue (NA) treatment discontinuation in non-cirrhotic patients with Chronic Hepatitis B (2022) (0)
- A VALIDATED ELISA FOR QUANTITATING HUMAN SERUM HEMOJUVELIN. (2013) (0)
- Table of contents (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonello Pietrangelo?
Antonello Pietrangelo is affiliated with the following schools:
